Pulmonary hypertension is a progressive and potentially life-threatening disorder requiring multidisciplinary management. This session will focus on the pathophysiology, diagnosis, and treatment of pulmonary vascular diseases. Researchers will discuss advances in risk stratification, biomarkers, and therapeutic interventions. Emerging research in pulmonary vascular biology will also be highlighted.
Presentations will examine pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, and associated syndromes. Participants will gain insights into imaging techniques, hemodynamic assessment, and individualized treatment strategies. Recent clinical trials and evidence-based guidelines will be discussed. Innovative therapies and future treatment approaches will also be explored.
The session will address challenges related to early diagnosis and long-term disease management. Experts will discuss translational opportunities and future perspectives in pulmonary hypertension research. Collaborative approaches aimed at improving patient outcomes will be emphasized. This session aims to advance comprehensive pulmonary vascular care.